OR WAIT null SECS
April 08, 2022
NIH has announced four new grant awards to fund new tuberculosis research advancement centers.
UK’s MHRA has issued a positive opinion for the Early Access to Medicines Scheme for radioligand therapy in patients with advanced prostate cancer.
April 07, 2022
INCOG Biopharma has completed the construction of its cleanroom production area, marking a milestone in the completion of an overall $100 million investment in a new facility.
Catalent has acquired the Vaccine Manufacturing Innovation Centre in Harwell, Oxford to expand its biologics capabilities across the UK and Europe.
PerkinElmer’s HTRF and AlphaLISA assay kits are designed to detect and quantify CHO host cell protein impurities.
The Thermo Scientific Ramina Process Analyzer is designed with user ease at the forefront.
April 06, 2022
Stanley Capital has announced the acquisition of MyMeds&Me by its portfolio company Drug Safety and Pharmacovigilance Services Solutions.
FDA has accepted Dupixent for Priority Review in patients aged 12 years and older with eosinophilic esophagitis.
ATMPS Ltd has been granted a patent from the United States Patent and Trademark Office for the use of its Hataali blockchain technology used in personalized medicines.
Merck has expanded its manufacturing facility in Elkton, Va. to further increase its HPV vaccine supply.